Basket

  Untick selected:   0
  1. HDAC3-mediated lncRNA-LOC101928316 contributes to cisplatin resistance in gastric cancer via activating the PI3K-Akt-mTOR pathway / Hengjie Ren, Liyun Tang. Neoplasma Vol. 68, no. 5 (2021), s. 1043-1051
    article

    article

  2. Guselkumab, prvý selektívny inhibítor interleukínu 23 schválený v liečbe ložiskovej psoriázy / Tomáš Kampe. Nové lieky Roč. 5, č. 5 (2018), s. 16-17
    article

    article


  This site uses cookies to make them easier to browse. Learn more about how we use cookies.